BCG-expressing tumor neoepitopes as cancer prophylactic vaccine
Principal researcher:
Alberto J. Schuhmacher
Managing entity:
Otros
Scope:
Nacional
Entidades participantes:
IIS Aragón
Universidad de Zaragoza
Number of researchers:
4
Start date:
09/2019
End date:
08/2021